People · Operator
Named in public records as an officer, director or promoter · active 2009–2011 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Meritage Pharma Inc | — | Pharmaceuticals | Series B | $38.5M | $221.0M | 2009 |
| Evoke Pharma Inc | — | Biotechnology | Series A | $6.0M | $216.9M | 2010 |
Malcolm R. Hill at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Malcolm R. Hill on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam L. Garner | 2 | 11 |
| Scott L. Glenn | 1 | 9 |
| David A. Gonyer | 1 | 2 |
| Adam K. Simpson | 1 | 2 |
| Kenneth J. Widder | 1 | 2 |
| James C. Blair, Ph.D. | 1 | 2 |
| Elaine M. Phillips, Ph.D. | 1 | 1 |
| Kenneth J. Widder, M.D. | 1 | 1 |
| Matt J. D'Onofrio | 1 | 1 |
| Todd L. Brady | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.